ArticleVeterinary sciences2025
Computed Tomographic Characteristics of Feline Renal Cell Carcinoma and Renal Lymphoma: A Comparative Analysis.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ultrasonographic features of feline renal neoplasia: a retrospective study on 187 cases.Journal of feline medicine and surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective, multicenter study aimed to identify key computed tomography (CT) features that differentiate renal cell carcinoma (RCC) from lymphoma, the two most common feline renal neoplasms. CT images from 25 cats with renal tumors (15 RCC and 10 lymphoma) were evaluated. Of the RCC cases, 10 were diagnosed through histopathology and 5 through FNA. Among the lymphoma cases, two were extranodal lymphoma, including one case of primary renal lymphoma, and eight were gastrointestinal (GI) lymphoma with renal involvement. Qualitative features (tumor distribution, growth pattern, and enhancement characteristics) and quantitative parameters (tumor size and attenuation values) from triphasic or single post-contrast-enhanced CT scans were analyzed and compared. RCC typically presented as unilateral (93.3%) masses with expansile growth (73.3%) and heterogeneous enhancement among contrast-enhancing tumors (100%). Lymphoma more often showed bilateral involvement (60%), infiltrative growth (50%), and homogeneous enhancement (90%) (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.